NS · Healthcare

Everest Organics Ltd (524790)

Pharmaceuticals & Biotechnology

Everest Organics Ltd (524790) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $2.67B, P/E ratio is 48.13, net margin is 0.7%, dividend yield is 0.18%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 524790

Market cap

$2.67B

P/E ratio

48.13

Net margin

0.7%

Dividend yield

0.18%

Everest Organics Ltd (524790) — FAQ

What is Everest Organics Ltd's market cap?

Everest Organics Ltd (524790) has a reported market cap of $2.67B (data as of 2026-07-10).

What is 524790's P/E ratio?

The price-to-earnings (P/E) ratio for Everest Organics Ltd (524790) is 48.13 (data as of 2026-07-10).

Does Everest Organics Ltd pay a dividend?

Everest Organics Ltd (524790) shows a reported dividend yield of 0.18%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Everest Organics Ltd in?

Everest Organics Ltd (524790) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 524790 listed on?

524790 is listed on NS.

What is Everest Organics Ltd's net margin?

Everest Organics Ltd (524790) reports a net margin of 0.7% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)